Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sustainable high market growth ahead with supportive margin recovery. There are limited tariff risks. Lonza is a potential beneficiary given the ample availability of the USA industrial capacities should biotech or pharma have onshoring needs. With profit growth higher than sales growth, we see a solid risk-reward setup. Our buy rating is confirmed.
Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Lonza Group AG (OTCPK:LZAGY) Q2 2024 Earnings Conference Call July 25, 2024 7:00 AM ET Company Participants Wolfgang Wienand - Chief Executive Officer Philippe Deecke - Chief Financial Officer Conference Call Participants Richard Vosser - JPMorgan Gary Steventon - BNP Exane James Vane-Tempest - Jefferies International Charles Pitman-King - Barclays Patrick Rafaisz - UBS Dylan van Haaften - Stifel Max Smock - William Blair Sebastian Bray - Berenberg Naresh Chouhan - Intron Health Falko Friedrichs - Deutsche Bank Daniel Jelovcan - ZKB Thibault Boutherin - Morgan Stanley Yifeng Liu - HSBC Lucas Baranowski - KeyBanc Capital Operator Ladies and gentlemen, welcome to the Half Year Results 2024 Investor and Analyst Conference Call and Live Webcast. I am Sandra, the Chorus Call operator.